2 Colchester Avenue
John Dewey Hall, Rm 224
Burlington, VT 05405-0134
United States
- B.A. Saint Bonaventure University, 1993
- Ph.D. University of Maine, 1998
Clinical Psychology
BIO
My primary research interests are the psychopathology and treatment of adult mood disorders, including:
- cognitive-behavioral models of depression onset, maintenance, and recurrence.
- cognitive-behavioral therapy for depression.
- subtypes of recurrent depression including seasonal affective disorder (SAD) and menstrual distress.
- treatment mediators/moderators
Rohan Laboratory
The Rohan Laboratory has recently completed a multi-year randomized clinical trial, funded by the National Institute of Mental Health, in which 141 community adults with seasonal affective disorder (SAD) were treated with either SAD-tailored cognitive-behavioral therapy (CBT-SAD) or with light therapy and followed over 2 years. This project applied the experimental therapeutics approach to determine the mechanisms through which CBT-SAD and light therapy work and to identify the best candidates for each. We are currently in the data processing and research dissemination phase. We are working on papers examining whether theoretically-derived candidate biomarkers of each treatment’s target and effect are prescriptive of better outcomes in one treatment vs. the other. We are working with data collected through pupillometry, EEG, and actigraphy.
Publications
Bio
My primary research interests are the psychopathology and treatment of adult mood disorders, including:
- cognitive-behavioral models of depression onset, maintenance, and recurrence.
- cognitive-behavioral therapy for depression.
- subtypes of recurrent depression including seasonal affective disorder (SAD) and menstrual distress.
- treatment mediators/moderators
Rohan Laboratory
The Rohan Laboratory has recently completed a multi-year randomized clinical trial, funded by the National Institute of Mental Health, in which 141 community adults with seasonal affective disorder (SAD) were treated with either SAD-tailored cognitive-behavioral therapy (CBT-SAD) or with light therapy and followed over 2 years. This project applied the experimental therapeutics approach to determine the mechanisms through which CBT-SAD and light therapy work and to identify the best candidates for each. We are currently in the data processing and research dissemination phase. We are working on papers examining whether theoretically-derived candidate biomarkers of each treatment’s target and effect are prescriptive of better outcomes in one treatment vs. the other. We are working with data collected through pupillometry, EEG, and actigraphy.